The association between obesity and the progression of prostate and renal cell carcinoma

Research output: Contribution to journalArticle

31 Citations (Scopus)

Abstract

Obesity has been linked to the incidence and mortality of several malignancies, including prostate and renal cancer. Increased body mass appears to have a more consistent association with prostate cancer mortality than incidence and recent studies suggest that it may be related to higher recurrence rates after radical prostatectomy. Obesity has an even stronger association with the development and progression of renal cancer, particularly in women. Since obesity is one of few modifiable risk factors that may impact the clinical course of these cancers, lifestyle and dietary changes to limit obesity should be recommended.

Original languageEnglish (US)
Pages (from-to)478-484
Number of pages7
JournalUrologic Oncology: Seminars and Original Investigations
Volume22
Issue number6
DOIs
StatePublished - Nov 2004
Externally publishedYes

Fingerprint

Renal Cell Carcinoma
Prostate
Obesity
Kidney Neoplasms
Prostatic Neoplasms
Mortality
Prostatectomy
Life Style
Neoplasms
Cohort Studies
Recurrence
Incidence

Keywords

  • Body mass index (BMI)
  • Obesity
  • Prostate cancer
  • Renal cell cancer

ASJC Scopus subject areas

  • Oncology
  • Urology

Cite this

@article{10dc53466186414cb295437e289cfb33,
title = "The association between obesity and the progression of prostate and renal cell carcinoma",
abstract = "Obesity has been linked to the incidence and mortality of several malignancies, including prostate and renal cancer. Increased body mass appears to have a more consistent association with prostate cancer mortality than incidence and recent studies suggest that it may be related to higher recurrence rates after radical prostatectomy. Obesity has an even stronger association with the development and progression of renal cancer, particularly in women. Since obesity is one of few modifiable risk factors that may impact the clinical course of these cancers, lifestyle and dietary changes to limit obesity should be recommended.",
keywords = "Body mass index (BMI), Obesity, Prostate cancer, Renal cell cancer",
author = "Christopher Amling",
year = "2004",
month = "11",
doi = "10.1016/j.urolonc.2004.10.004",
language = "English (US)",
volume = "22",
pages = "478--484",
journal = "Urologic Oncology: Seminars and Original Investigations",
issn = "1078-1439",
publisher = "Elsevier Inc.",
number = "6",

}

TY - JOUR

T1 - The association between obesity and the progression of prostate and renal cell carcinoma

AU - Amling, Christopher

PY - 2004/11

Y1 - 2004/11

N2 - Obesity has been linked to the incidence and mortality of several malignancies, including prostate and renal cancer. Increased body mass appears to have a more consistent association with prostate cancer mortality than incidence and recent studies suggest that it may be related to higher recurrence rates after radical prostatectomy. Obesity has an even stronger association with the development and progression of renal cancer, particularly in women. Since obesity is one of few modifiable risk factors that may impact the clinical course of these cancers, lifestyle and dietary changes to limit obesity should be recommended.

AB - Obesity has been linked to the incidence and mortality of several malignancies, including prostate and renal cancer. Increased body mass appears to have a more consistent association with prostate cancer mortality than incidence and recent studies suggest that it may be related to higher recurrence rates after radical prostatectomy. Obesity has an even stronger association with the development and progression of renal cancer, particularly in women. Since obesity is one of few modifiable risk factors that may impact the clinical course of these cancers, lifestyle and dietary changes to limit obesity should be recommended.

KW - Body mass index (BMI)

KW - Obesity

KW - Prostate cancer

KW - Renal cell cancer

UR - http://www.scopus.com/inward/record.url?scp=21644439697&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=21644439697&partnerID=8YFLogxK

U2 - 10.1016/j.urolonc.2004.10.004

DO - 10.1016/j.urolonc.2004.10.004

M3 - Article

VL - 22

SP - 478

EP - 484

JO - Urologic Oncology: Seminars and Original Investigations

JF - Urologic Oncology: Seminars and Original Investigations

SN - 1078-1439

IS - 6

ER -